SE9904677D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904677D0
SE9904677D0 SE9904677A SE9904677A SE9904677D0 SE 9904677 D0 SE9904677 D0 SE 9904677D0 SE 9904677 A SE9904677 A SE 9904677A SE 9904677 A SE9904677 A SE 9904677A SE 9904677 D0 SE9904677 D0 SE 9904677D0
Authority
SE
Sweden
Prior art keywords
novel compounds
compounds
tocether
racemates
tautomers
Prior art date
Application number
SE9904677A
Other languages
English (en)
Inventor
James E Macdonald
Kenneth Mattes
Robert J Murray
Hans F Schmitthenner
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9904677A priority Critical patent/SE9904677D0/sv
Publication of SE9904677D0 publication Critical patent/SE9904677D0/sv
Priority to US09/763,838 priority patent/US20020137750A1/en
Priority to AU25636/01A priority patent/AU2563601A/en
Priority to PCT/SE2000/002540 priority patent/WO2001046171A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9904677A 1999-12-20 1999-12-20 Novel compounds SE9904677D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9904677A SE9904677D0 (sv) 1999-12-20 1999-12-20 Novel compounds
US09/763,838 US20020137750A1 (en) 1999-12-20 2000-12-14 Amidine derivatives which are inhibitors of nitric oxide synthase
AU25636/01A AU2563601A (en) 1999-12-20 2000-12-14 Amidine derivatives which are inhibitors of nitric oxide synthase
PCT/SE2000/002540 WO2001046171A1 (en) 1999-12-20 2000-12-14 Amidine derivatives which are inhibitors of nitric oxide synthase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904677A SE9904677D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904677D0 true SE9904677D0 (sv) 1999-12-20

Family

ID=20418213

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904677A SE9904677D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Country Status (4)

Country Link
US (1) US20020137750A1 (sv)
AU (1) AU2563601A (sv)
SE (1) SE9904677D0 (sv)
WO (1) WO2001046171A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020511A1 (en) * 2000-09-05 2002-03-14 Astrazeneca Ab Amidine derivatives which are inhibitors of nitric oxide synthase
DE10162114A1 (de) * 2001-12-12 2003-06-26 Schering Ag Neue Amidin-Derivate und deren Verwendung in Arzneimitteln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6286294A (en) * 1993-03-23 1994-10-11 Astra Aktiebolag Guanidine derivatives useful in therapy
IL110643A (en) * 1993-08-12 1998-07-15 Astra Ab History of amidine, their preparation and the pharmaceutical preparations containing them
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
JPH10265450A (ja) * 1997-03-25 1998-10-06 Mitsui Chem Inc 一酸化窒素合成酵素阻害作用を有する新規なアミジン誘導体

Also Published As

Publication number Publication date
US20020137750A1 (en) 2002-09-26
AU2563601A (en) 2001-07-03
WO2001046171A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
SE0302487D0 (sv) Novel compounds
SE0202463D0 (sv) Novel compounds
MY137133A (en) Novel compounds
MY143400A (en) 2-pyridone derivatives as neutrophil elastase inhibitors and their use
SE0302324D0 (sv) Novel compounds
MXPA03010142A (es) Nuevos derivados de arilheteroalquilamina.
SE0302323D0 (sv) Novel compounds
SE9803518D0 (sv) Novel compounds
SE0203304D0 (sv) Novel Coumpounds
SE0302756D0 (sv) Novel Compounds
SE9803773D0 (sv) Compounds
SE0202461D0 (sv) Novel compounds
NZ322227A (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
SE9904676D0 (sv) Novel compounds
SE9901901D0 (sv) Compounds
ATE265423T1 (de) Neue phenylheteroalkylamin-derivate
SE9904677D0 (sv) Novel compounds
SE0000477D0 (sv) Novel compounds
WO2003011210A3 (en) Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
SE0103325D0 (sv) Novel compounds
BR0108539A (pt) Novo uso de derivados de fenilheteroalquilamina
SE0202280D0 (sv) Novel compounds
SE9901530D0 (sv) Novel compounds
SE9802650D0 (sv) Compounds
SE0302120D0 (sv) Novel compounds